Selected
Reports from the
American
Association for the Study of Liver Diseases
51th Annual Meeting, Dallas
Dallas,
Texas,
October 2000
Efficacy of
Interferon Plus Ribivarin Combination Treatment and Impact on HIV
Infection in Hemophiliacs with Chronic HCV and Under HAART
Interferon+Ribivarin in 19 HCV/HIV Coinfected Hemophiliacs
Reported at AASLD
Does Amantadine Help
Response to HCV Therapy?
Pegasys Combinations
With Amantadine, Ribivarin + Amantadine, and Mycophenolate Acid
Can Persons With Decompensated
Cirrhosis Be Treated for HCV?
HCV,
HAART, & Diabetes
What is the Association Between Diabetes & HCV &
HAART?
Mitochondrial Abnormalities
in HCV and HCV/HIV Coinfection
Coinfected patients mount broad &
strong response to HIV but not HCV.
Weight Reduction
May Improve Fibrosis, ALT, Insulin & Triglycerides in Chronic HCV
Weight
Reduction In Patients With Chronic Hepatitis C Improves LIver Histology
& Biochemistry
18 Months Interferon+Ribivarin Reduces Relapse Rate Compared
to 6 Months Treatment
Low Relapse Rate in
Chronic Hepatitis C Treated with 18 Months Interferon-Alpha &
Ribavirin as Compared to 6 Months Combination Therapy and to 18 Months
Monotherapy. A Benelux Study in 300 Patients.
INTERFERON RESISTANCE:
Hepatitis C Virus Resistance to Antiviral Therapy
in PDF format only
By
Jean Michel Pawlotsky
Summary of 1 Day Conference Held at NIH in
December 1999 entitled "Hepatitis C in African-Americans"
(excerpted
from Gastroenterology 2000; 119: 1385-1396)
also, PDF version of entire article
Summary of the AASLD Meeting - Hepatology,
October 2000 supplement
Written for
NATAP by
Ray Chung, MD, Director of Transplantation, Massachusetts
General Hospital, Boston
Live Reports from Dallas
Written
by Jules Levin
Report
8
HIV
Medications & HCV at Dallas AASLD Conference: More Research Needed
Reported by Jules Levin
Histologic Patten of Liver Injury in HIV-Positive Patients on HAART:
A Possible Hepatotoxic Effect
of Protease Inhibitors
Hepatotoxicity Associated with Non-nucleoside Reverse Transcriptase
Inhibitors for the Treatment of Human Immunodeficiency Virus and the Effect
of Hepatitis B or C Virus Infection
Additional reports are being prepared and will be posted as each is finished.